Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Comparative Analysis of Clinical Manifestations of Gasless Endoscopic Surgery via Transaxillary and Subclavicular Approaches in Unilateral cN0 Thyroid Cancer.

Created on 18 Aug 2026

Authors

Xiaoshi Li, Anke Jiang, Qinglin Hu

Published in

Annali italiani di chirurgia. Volume 97. Issue 8. Pages 1433-1442. Aug 13, 2026.

Abstract

To compare the clinical efficacy and safety of gasless endoscopic radical thyroidectomy via the transaxillary approach versus the subclavicular approach for unilateral cN0 thyroid cancer.
A total of 415 patients with unilateral cN0 thyroid cancer admitted between January 2022 and May 2025 were retrospectively included. After propensity score matching (PSM), patients were divided into Group A (gasless endoscopic radical thyroidectomy via the transaxillary approach, n = 57) and Group B (gasless endoscopic radical thyroidectomy via the subclavicular approach, n = 57). The clinical outcomes of these two approaches were compared.
Group B had significantly shorter operative time, lower postoperative drainage volume, and a higher rate of complete central compartment exposure than Group A (p < 0.05). Repeated-measures analysis of variance (ANOVA) showed significant main effects of time, group, and time-by-group interaction for interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), incision pain scores, parathyroid hormone (PTH), and Quality of Life Questionnaire-Core 30 (QLQ-C30) scores (p < 0.05). Group B had a lower total complication rate and higher aesthetic satisfaction scores at 1 and 3 months postoperatively than Group A (p < 0.001).
Gasless endoscopic radical thyroidectomy via the subclavicular approach demonstrated potential short-term advantages over the transaxillary approach, including shorter operative time, improved central compartment exposure, attenuated inflammatory response, milder early postoperative pain, and more favorable trends in PTH levels and early quality-of-life recovery. However, given the limited 3-month follow-up period, the absence of significant differences in clinical hypocalcemia rates, and the lack of long-term oncological outcomes, these findings should be interpreted with caution.

PMID:
42610290
Bibliographic data and abstract were imported from PubMed on 18 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement